Surgery Partners Stock Forecast, Price & News

-1.95 (-4.47 %)
(As of 04/20/2021 12:21 PM ET)
Today's Range
Now: $41.70
50-Day Range
MA: $42.48
52-Week Range
Now: $41.70
Volume10,668 shs
Average Volume468,681 shs
Market Capitalization$2.50 billion
P/E RatioN/A
Dividend YieldN/A
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2020, it owned or operated a portfolio of 127 surgical facilities, including 110 ambulatory surgical centers and 17 surgical hospitals in 30 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Surgery Partners logo

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Current SymbolNASDAQ:SGRY
Year FoundedN/A



Sales & Book Value

Annual Sales$1.83 billion
Cash Flow$0.69 per share
Book Value$19.67 per share


Net Income$-74,800,000.00


Market Cap$2.50 billion
Next Earnings Date5/5/2021 (Confirmed)


Surgery Partners (NASDAQ:SGRY) Shares Gap Down to $45.45
April 13, 2021 |
Surgery Partners (NASDAQ:SGRY) Sets New 12-Month High at $45.85
April 6, 2021 |
Surgery Partners (NASDAQ:SGRY) Sets New 52-Week High at $44.98
March 29, 2021 |
Earnings Preview: Surgery Partners
March 11, 2021 |
Surgery Partners: Q4 Earnings Insights
March 10, 2021 |
Surgery Partners: Q4 Earnings Snapshot
March 10, 2021 |
Surgery Partners Inc. Registere (1SP.SG)
February 18, 2021 |
SGRY Feb 2021 50.000 call
February 11, 2021 |
SGRY Feb 2021 40.000 put
February 10, 2021 |
SGRY Feb 2021 30.000 put
January 25, 2021 |
See More Headlines


Overall MarketRank

1.18 out of 5 stars

Medical Sector

935th out of 2,018 stocks

General Medical & Surgical Hospitals Industry

3rd out of 11 stocks

Analyst Opinion: 1.4Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
-1.95 (-4.47 %)
(As of 04/20/2021 12:21 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SGRY News and Ratings via Email

Sign-up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

Is Surgery Partners a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Surgery Partners stock.
View analyst ratings for Surgery Partners
or view top-rated stocks.

What stocks does MarketBeat like better than Surgery Partners?

Wall Street analysts have given Surgery Partners a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Surgery Partners wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Surgery Partners

How can I listen to Surgery Partners' earnings call?

Surgery Partners will be holding an earnings conference call on Wednesday, May 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) announced its earnings results on Tuesday, March, 9th. The company reported $0.09 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.02 by $0.07. The company had revenue of $548.30 million for the quarter. Surgery Partners had a negative net margin of 7.64% and a negative trailing twelve-month return on equity of 4.73%.
View Surgery Partners' earnings history

How has Surgery Partners' stock been impacted by COVID-19 (Coronavirus)?

Surgery Partners' stock was trading at $8.86 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SGRY shares have increased by 370.7% and is now trading at $41.70.
View which stocks have been most impacted by COVID-19

What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners updated its first quarter 2021 Pre-Market earnings guidance on Tuesday, April, 20th. The company provided EPS guidance of for the period. The company issued revenue guidance of $505 million, compared to the consensus revenue estimate of $495.83 million.

What price target have analysts set for SGRY?

7 brokers have issued 1 year target prices for Surgery Partners' shares. Their forecasts range from $17.50 to $54.00. On average, they expect Surgery Partners' share price to reach $31.07 in the next year. This suggests that the stock has a possible downside of 25.5%.
View analysts' price targets for Surgery Partners
or view top-rated stocks among Wall Street analysts.

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the following people:
  • Mr. Wayne Scott DeVeydt, Exec. Chairman (Age 51, Pay $1.34M)
  • Mr. J. Eric Evans, CEO & Director (Age 43, Pay $880.74k)
  • Mr. Thomas Francis Cowhey, Exec. VP & CFO (Age 49, Pay $756.8k)
  • Ms. Jennifer B. Baldock, Exec. VP, Chief Admin. & Devel. Officer (Age 50, Pay $624.98k)
  • Mr. George M. Goodwin, American Group Pres (Age 60, Pay $627.06k)
  • Mr. Clifford G. Adlerz, Consultant & Director (Age 67, Pay $75k)
  • Mr. Matt Petty, Sr. VP & Chief Information Officer
  • Ms. Roxanne Womack, Sr. VP & Chief Compliance Officer
  • Ms. Laura L. Brocklehurst, Sr. VP & Chief HR Officer (Age 50)
  • Mr. Anthony W. Taparo, Chief Growth Officer (Age 54)

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners CEO Eric Evans on Eric Evans has an approval rating of 86% among Surgery Partners' employees.

Who are some of Surgery Partners' key competitors?

What other stocks do shareholders of Surgery Partners own?

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (0.17%) and Hennessy Advisors Inc. (0.12%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Jason Eric Evans and Teresa Deluca.
View institutional ownership trends for Surgery Partners

Which institutional investors are buying Surgery Partners stock?

SGRY stock was bought by a variety of institutional investors in the last quarter, including Hennessy Advisors Inc., and Calamos Advisors LLC. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans, and Teresa Deluca.
View insider buying and selling activity for Surgery Partners
or or view top insider-buying stocks.

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $41.70.

How much money does Surgery Partners make?

Surgery Partners has a market capitalization of $2.50 billion and generates $1.83 billion in revenue each year. The company earns $-74,800,000.00 in net income (profit) each year or ($1.10) on an earnings per share basis.

How many employees does Surgery Partners have?

Surgery Partners employs 9,100 workers across the globe.

What is Surgery Partners' official website?

The official website for Surgery Partners is

Where are Surgery Partners' headquarters?

Surgery Partners is headquartered at 310 Seven Springs Way Suite 500, Brentwood TN, 37027.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]

This page was last updated on 4/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.